STEVEN WELLS: Open Payments
NPI 1003395427 · RUSSELLVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,571 in 86 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,571
Food & beverage: $1,571
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $545 |
| Amgen Inc. | 26 | $432 |
| UCB, Inc. | 9 | $285 |
| Lilly USA, LLC | 5 | $105 |
| Radius Health, Inc. | 2 | $62 |
| Genentech USA, Inc. | 3 | $50 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Organon LLC | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: RINVOQ, Bimzelx, ENBREL, SKYRIZI, TALTZ, EVENITY, OTEZLA, Tymlos.
Industry payments across AR — which companies pay providers there.
